Verzögert
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
6.33 HKD | +1.77% | +8.02% | -12.81% |
24.04. | EBT von CSPC Pharmaceutical kauft 8,5 Millionen Aktien | MT |
19.04. | CSPC Pharmaceutical Group Limited und CSPC Holdings Company Limited schließen Rahmenvertriebsvertrag ab | CI |
ETFs investiert in CSPC Pharmaceutical Group Ltd.
Name | Gewichtung | Volumen | % 1. Jan. | Investm. Rating |
---|---|---|---|---|
4,05% | 2 M€ | -19.10% | - | |
2,02% | 4 M€ | -27.92% | ||
1,07% | 3 M€ | -3.61% | - | |
0,99% | 2 M€ | -14.14% | ||
0,86% | 4 M€ | -11.56% | ||
0,53% | 18 M€ | +2.25% | ||
0,26% | 11 M€ | +0.51% | ||
0,23% | 35 M€ | -5.85% | - | |
0,23% | 1 M€ | +3.49% | - | |
0,23% | 3 M€ | -.--% | - | |
0,10% | 441 M€ | +3.59% | - | |
0,10% | 2 808 M€ | +4.56% | - | |
0,10% | 149 M€ | +0.93% | - | |
0,09% | 117 M€ | +0.68% | - | |
0,08% | 4 M€ | -4.41% | - | |
0,05% | 0 M€ | 0.00% | - | |
0,04% | 31 M€ | +3.05% | - | |
0,03% | 7 M€ | +0.11% | - | |
0,02% | 389 M€ | +6.30% | - | |
0,02% | 34 M€ | +5.86% | - | |
0,01% | 7 M€ | +1.70% | - | |
0,01% | 39 M€ | +3.93% | - | |
0,01% | 302 M€ | +3.73% | - | |
0,01% | 17 M€ | +1.23% | - | |
0,01% | 34 M€ | +2.35% | - | |
0,01% | 108 M€ | +2.05% | - | |
0,01% | 147 M€ | +4.84% | - |
Verlauf des Gewinns je Aktie
% 1. Jan. | Kap. | |
---|---|---|
-12.81% | 9.14 Mrd. | |
+25.61% | 672 Mrd. | |
+25.87% | 570 Mrd. | |
-5.24% | 360 Mrd. | |
+16.49% | 321 Mrd. | |
+8.28% | 300 Mrd. | |
+7.09% | 217 Mrd. | |
-9.12% | 204 Mrd. | |
+5.01% | 199 Mrd. | |
-8.75% | 149 Mrd. |
- Börse
- Aktien
- 548183 Aktie
- ETFs CSPC Pharmaceutical Group Ltd.